FDA
.report
PMA
PMN
De Novo
MAUDE
GUDID
NDC
DailyMed
Drug Applications
FDA Letter EXELA PHARMA ANDA 212071
Letter
ANDA 212071
EXELA PHARMA
FDA.report
›
FDA Drug Approvals
›
EXELA PHARMA
›
ANDA 212071
›
Letter
Application #212071
Documents
Letter
2022-12-20
Application Sponsors
ANDA 212071
EXELA PHARMA
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.